Cryselle
Product Images NDC 53002-1188

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cryselle (NDC 53002-1188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00555904958part1of2

FDA Label Image

00555904958part2of2

FDA Label Image

Norgestrel Strustural Formula (Image 1)

FDA Label Image

Ethinyl Estradiol Structural Formula (Image 2)

FDA Label Image

Chart 1 (Image 3)

This text describes different methods of birth control and their effectiveness. It mentions the number of pregnancies that occur per 100 women in one year using these methods, ranging from 10-20 pregnancies to 85 or more. Various birth control options are also listed, including implants, injections, intrauterine devices, sterilization, and birth control pills. The text also suggests abstinence as a method of birth control during the most fertile days, and notes the absence of birth control in the last line.*

FDA Label Image

28 Pill Pack Blister Image (Image 4)

FDA Label Image

Pick Correct Day Label Blister Image (Image 5)

FDA Label Image

Label Image (Lbl530021188)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.